ArticleNeurology(R) neuroimmunology & neuroinflammation2017
Both cladribine and alemtuzumab may effect MS via B-cell depletion.
David Baker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
80 papers cite itlatest 60 shown
this paperpooled ittrialcites it